First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous ...
The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...
Sanofi and Roche reported fourth-quarter and full-year 2025 earnings. Summit Therapeutics said the FDA accepted its application seeking approval of its PD-1/VEGF antibody ivonescimab to treat ...
To be clear, there are laudable ideas, from a public health perspective, in the new guidelines. There is good reason to believe that ultra-processed foods (although difficult to define) are linked ...
This week on "The Readout LOUD": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high ...
A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
AstraZeneca will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development ...
A majority of respondents (67%) say Congress did the “wrong thing” by not yet extending the ACA enhanced premium tax credits, ...
How big of a role do our genes play in our lifespan? Quite a bit more than previously thought, a new study suggests.
Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work requirements, the Trump administration announced Thursday, signaling how ...
The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the announcement was light on details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results